A detailed history of Frank, Rimerman Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 5,122 shares of ZTS stock, worth $905,108. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,122
Previous 8,880 42.32%
Holding current value
$905,108
Previous $1.54 Million 35.02%
% of portfolio
0.07%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$172.58 - $196.48 $648,555 - $738,371
-3,758 Reduced 42.32%
5,122 $1 Million
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $1.29 Million - $1.58 Million
8,861 Added 46636.84%
8,880 $1.54 Million
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $2,877 - $3,801
19 New
19 $3.75 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.